- Home
- INSE vs NKTR Comparison
INSE vs NKTR Comparison
Compare INSE & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSE
- NKTR
- Stock Information
- Founded
- INSE N/A
- NKTR 1990
- Country
- INSE United States
- NKTR United States
- Employees
- INSE N/A
- NKTR N/A
- Industry
- INSE Computer Software: Prepackaged Software
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- INSE Technology
- NKTR Health Care
- Exchange
- INSE Nasdaq
- NKTR Nasdaq
- Market Cap
- INSE 245.3M
- NKTR 247.9M
- IPO Year
- INSE N/A
- NKTR 1994
- Fundamental
- Price
- INSE $8.52
- NKTR $0.93
- Analyst Decision
- INSE Buy
- NKTR Buy
- Analyst Count
- INSE 3
- NKTR 3
- Target Price
- INSE $15.00
- NKTR $4.00
- AVG Volume (30 Days)
- INSE 158.1K
- NKTR 2.3M
- Earning Date
- INSE 11-07-2024
- NKTR 11-07-2024
- Dividend Yield
- INSE N/A
- NKTR N/A
- EPS Growth
- INSE N/A
- NKTR N/A
- EPS
- INSE N/A
- NKTR N/A
- Revenue
- INSE $297,900,000.00
- NKTR $93,137,000.00
- Revenue This Year
- INSE N/A
- NKTR $12.85
- Revenue Next Year
- INSE $4.15
- NKTR N/A
- P/E Ratio
- INSE N/A
- NKTR N/A
- Revenue Growth
- INSE N/A
- NKTR 5.53
- 52 Week Low
- INSE $7.51
- NKTR $0.47
- 52 Week High
- INSE $11.00
- NKTR $1.93
- Technical
- Relative Strength Index (RSI)
- INSE 28.92
- NKTR 33.04
- Support Level
- INSE $8.99
- NKTR $0.89
- Resistance Level
- INSE $9.20
- NKTR $1.04
- Average True Range (ATR)
- INSE 0.39
- NKTR 0.07
- MACD
- INSE -0.12
- NKTR -0.00
- Stochastic Oscillator
- INSE 5.13
- NKTR 14.81
About INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments namely Gaming; Virtual Sports; Interactive and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.